Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. International Journal of Endocrinology and Metabolism
  4. Articles

  5. WITHDRAWN ARTICLE: Effect of Sesame Lignan Supplementation on Carotid Intima-Media Thickness, Serum Lipid Profile, Serum VEGF, VCAM-1, ICAM-1 and vWF Levels in Cardiovascular Disease Patients
  6. Crossref

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Home
Current IssueAll IssuesIn PressSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref


1. Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose–response meta-analysis

- Ali Jafari

- Bahare Parsi Nezhad

- Niloufar Rasaei

- Elahe Aleebrahim-Dehkordi

- Abdolhalim Rajabi

- Alireza Alaghi

2. Susamın (Sesamum indicum L.) Kardiyovasküler Hastalıklarla İlişkisi

- Dilara Berşan Konyalıgil

- Kübra Tel Adıgüzel

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.